🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Hepatopulmonary Syndrome - or is Portopulmonary hypertension? What’s the diff (brief #tweetorial) Pulm complications of #cirrhosis can be devastating. This month on rounds, I was reminded that these conditions are confusing. #meded

#CGH4ALL CGH 📣 🤔 Is Your ZIP Code a Predictor of MASLD Mortality? 🎯 Counties w/⬆️MASLD related mortality had⬆️ Food swamps and deserts 👀 Read more 🔗 doi.org/10.1016/j.cgh.… Dr SALEH ALQAHTANI James M. Paik Mazen Noureddin, MD, MHSc Brian T Lee MD Daniel Huang Zobair Younossi Rohit Loomba

📢 It’s OVER. The “lean MASLD paradox”? Just bad measurement. ❎MASLD with overweight BMI weren’t healthier! We were using the wrong metric. ↗️Waist circumference-related indices show a dose-dependent mortality risk across 3 prospective cohorts. Let’s reframe how we assess

In the #RedJournal:   Higher Rate of Spontaneous Bacterial Peritonitis Recurrence With Secondary Spontaneous Bacterial Peritonitis Prophylaxis Compared With No Prophylaxis in 2 National Cirrhosis Cohorts Silvey, et al.   📕 bit.ly/4jav0Zz Jasmohan Bajaj Millie Long

Can FIB-4 then VCTE detect sig. fibrosis in MetALD? = Yes read Luis Antonio Díaz, MD paper MASLD Research Center Noninvasive pathway for stratifying fibrosis in suspected metabolic dysfunction and alcohol-associated liver diseas… pubmed.ncbi.nlm.nih.gov/40377491/ AASLD Elliot Tapper

👎We’re failing patients with alcohol-associated liver disease 🏥 ALD admissions: 11.5k → 37.5k (2014–2023) Among ALD admissions, within 1 year post-discharge: 💊 Medication rates barely reached 24% 🧠 Any psychiatric visit remained at 6.5% in 2023!!! 👥 Sex disparity:

🧬New 📋 Veeral Ajmera Journal of Hepatology: In MASLD, inherited genetic risk drives age-associated fibrosis. ⬆️ LSMs after 40y in high-risk genotypes 🧪 PNPLA3 genotyping may improve risk stratification 📈 Supports personalized medicine 🔗 doi.org/10.1016/j.jhep… Rohit Loomba UCSD Gastroenterology

Statin Use Is Associated With Protection Against Acute Cholangitis in Patients With Primary Sclerosing Cholangitis: A Multicenter Retrospective Cohort Study Kulkarni, et al.   ➡️ bit.ly/3STyyVs George Cholankeril Aparna Goel, MD (she/her) ACG Brian Jacobson

Statin use is associated with lower risks of hepatocellular carcinoma (HCC) and hepatic decompensation, and improved fibrosis progression in patients with chronic liver disease. ja.ma/3Sgs5np

In the #RedJournal: Tumor Seeding With Needle Biopsy of Hepatocellular Carcinoma: A Systematic Review Nie, et al. 📕 bit.ly/3GUswBv Chunpeng Nie Kelly Warren Burak Stephen Congly

#CGH4ALL CGH 📣 Check out this population-based studies on DILI due to the most commonly implicated drugs! Prior studies may have underestimated the incidence! (previously 2.7/100000 estimates) Reported by Zaid Ansari 🔗 cghjournal.org/article/S1542-… Timothy Li TheLiverDoc

Naltrexone is not contraindicated in cirrhosis There is no evidence of harm Only evidence of benefit Do we know for certain it is safe in Child C cirrhosis? No! Nothing is certain in child C cirrhosis.

1/🚨Check out our new study in Journal of Hepatology❗️ Using natural language processing to identify >350,000 patients with #steatosis, we demonstrated that cause-specific mortality differs between #MASLD, #MetALD, and #ALD #LiverTwitter #LiverX @PennGiHep pubmed.ncbi.nlm.nih.gov/40419118/

📣New data on cirrhosis recompensation in Journal of Hepatology ✅Only 7% meets strict Baveno VII criteria ✅Expanded criteria capture ~38% with similar low mortality risk Recompensation: ⬇️systemic inflammation🔥 👍 improved hemodynamic ⬆️improved survival doi.org/10.1016/j.jhep…

Review Advances in imaging—Elastography Dajti et al. #LiverX tinyurl.com/stxxfad9

Del Piero: "Cheering for Inter? Unthinkable." I love this man. Forever my captain

Review Portal sinusoidal vascular diseases: Assessment and therapy Mironova et al. #LiverX tinyurl.com/56yde2p9

People often ask me: do you recommend NON-ALCOHOLIC BEER to patients that continue to drink regular beer? Although it can be a practical solution, it has two risks: - It predicts returning to alcoholic beverages. - This paper shows that its sugar content is metabolically bad.